Important: Therapy notes
NPS alert: Harm from delayed administration of rasburicase for tumour lysis syndrome (September 2025) (NatPSA/2025/005/NHSPS).
Allopurinol and rasburicase are used to prevent, and rasburicase is also used to treat, hyperuricaemia associated with cytotoxic drugs.
NPS alert: Harm from delayed administration of rasburicase for tumour lysis syndrome (September 2025) (NatPSA/2025/005/NHSPS).